Scott Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 7.60 M
- Company Age 18 Year, 4 Months
- Last Filing with ROC 31 Mar 2017
- Satisfied Charges ₹ 0.80 M
About Scott Biotech
Scott Biotech Private Limited (SBPL) is a Private Limited Indian Non-Government Company incorporated in India on 25 September 2006 and has a history of 18 years and four months. Its registered office is in Delhi, India.
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2017. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 7.60 M.
The company has closed loans amounting to ₹0.80 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Rahul, Himanshu Mann, Arun Mann, and One other member serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24233DL2006PTC154282
- Company No.
154282
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Sep 2006
- Date of AGM
20 Sep 2017
- Date of Balance Sheet
31 Mar 2017
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Scott Biotech?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rahul  | Director | 18-Aug-2010 | Current |
| Himanshu Mann | Additional Director | 16-Aug-2010 | Current |
| Arun Mann | Additional Director | 16-Aug-2010 | Current |
| Gaurav Shokeen | Additional Director | 26-Nov-2011 | Current |
Financial Performance of Scott Biotech.
Scott Biotech Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Scott Biotech?
In 2017, Scott Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sakshi Buildmark Private LimitedRahul and Gaurav Shokeen are mutual person
Charges (Loans)
₹0
₹0.08 Cr
Charges Breakdown by Lending Institutions
- Oriental Bank Of Commerce : 0.08 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Jun 2008 | Oriental Bank Of Commerce | ₹0.80 M | Satisfied |
How Many Employees Work at Scott Biotech?
Unlock and access historical data on people associated with Scott Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Scott Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Scott Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
